Sort   by:  
 Page size 
UnknownPhase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results.
Not available
S-EPMC7694337 | biostudies-literature
UnknownCapecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study.
Not available
S-EPMC4423590 | biostudies-literature
UnknownSEOM Clinical Guideline for bone metastases from solid tumours (2016).
Not available
S-EPMC5138247 | biostudies-literature
UnknownSEOM clinical guideline for treatment of cancer pain (2017).
Not available
S-EPMC5785609 | biostudies-literature
UnknownClinical management of regorafenib in the treatment of patients with advanced colorectal cancer.
Not available
S-EPMC4194027 | biostudies-literature
UnknownEffect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial.
Not available
S-EPMC8927487 | biostudies-literature
UnknownImpact of Total Neoadjuvant Therapy vs. Standard Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis of Randomized Trials.
Not available
S-EPMC7762140 | biostudies-literature
UnknownEfficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial.
Not available
S-EPMC5239803 | biostudies-literature
UnknownVariants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer.
Not available
S-EPMC4467446 | biostudies-literature
UnknownDefinition of lines of treatment in metastatic colorectal cancer: a Delphi consensus.
Not available
S-EPMC12855278 | biostudies-literature
Sort   by:  
 Page size